Related Experiment Video

Updated: Dec 7, 2025

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

12.4K

No evidence for the effectiveness of IV ketamine for treatment resistant mood disorders in retrospective study

Klaus Munkholm1, Karsten J Jørgensen1

  • 1Nordic Cochrane Centre, Copenhagen, Denmark.

Bipolar Disorders
|September 27, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.4K
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:36

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

68

Related Experiment Videos

Last Updated: Dec 7, 2025

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

12.4K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.4K
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:36

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

68

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

486
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
486
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

356
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
356

Articles linked to this work by shared authors, journal, and citation graph.

Neural subgroups in unaffected first-degree relatives of patients with bipolar disorder during emotion regulation.

Psychological medicine·2025

Early specialised treatment for bipolar disorder: Long-term follow-up from the early intervention in affective disorders (EIA) randomised controlled trial.

Acta psychiatrica Scandinavica·2024

Minor tranquillizers for short-term treatment of newly onset symptoms of anxiety and distress: a systematic review with network meta-analysis of randomized trials.

European archives of psychiatry and clinical neuroscience·2023

Are investigators' access to trial data and rights to publish restricted and are potential trial participants informed about this? A comparison of trial protocols and informed consent materials.

BMC medical ethics·2021

Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review.

BMJ (Clinical research ed.)·2020

Individual response to antidepressants for depression in adults-a meta-analysis and simulation study.

PloS one·2020

Developing and Validating a Patient-Centered Measure of Well-Being in Bipolar Disorder: The WELL-B.

Bipolar disorders·2026

Women With Bipolar Disorder are at Increased Risk of Sarcopenia.

Bipolar disorders·2026

Comparison of Clinical Indicators for Differentiating Unipolar and Bipolar Depression.

Bipolar disorders·2026

Clinical Symptomatology as Predictors of Early Treatment Response in Adolescents and Young Adults With Major Depressive Episode.

Bipolar disorders·2026

The Impact of Sexual Satisfaction on Marital Adjustment, Quality of Life, and Treatment Adherence in Patients Diagnosed With Bipolar Disorder and Their Spouses: A Cross-Sectional Study.

Bipolar disorders·2026

Emotional Responses (Intensity/Valence) Fulfill RDoC Criteria but Remain Excluded From Diagnostic Classifications of Mood Disorders.

Bipolar disorders·2026

Late-Onset Erotomanic Delusions, Cognitive Impairment, and Ventriculomegaly in an Older Adult Without Prior Psychiatric History: A Neuropsychiatric Case Report.

Brain sciences·2026

Potential misclassification of probable sporadic Creutzfeldt-Jakob disease diagnosed without PRNP testing.

Journal of the neurological sciences·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us